top of page
Discover
The Latest From Our PRN Community
Welcome to our blog by PRN members for PRN members, filled with unique and engaging content to explore, connect, and engage with the world of ambulatory care pharmacy!

Search


What Ambulatory Care Pharmacists Should Know About 2025 Medicare Part D Updates
Written by Ardis M. Copenhaver, PharmD, MS, BCPS Some of Medicare Part D changes from the passage of Inflation Reduction Act of 2022 have come into effect in January 2025. The goal of this legislation is to provide further support on prescription drug benefits for the adults aged 65 and older and those individuals with qualifying disabilities. The two big 2025 changes include the elimination of the “Donut Hole” with the reduction of out-of-pocket (OOP) costs and the launch of
Nov 12, 20254 min read


Expanding Access to Care: Implementation of an Audible Prescription Labeling System (APLS) at Johns Hopkins Community Pharmacies
Written by Ally Rhea, PharmD Candidate 2027; Sai Wright, PharmD, MBA, MSPH; Laurel Uhomba, PharmD, MBA, MPH Nearly 12 million adults over the age of 40 in the United States are living with vision loss, which may significantly impact their ability to manage medications safely.(1) Prescription labels are often printed in small fonts that are not accessible to visually impaired individuals. Without the ability to read medication names, instructions, or warnings, patients may fa
Oct 30, 20253 min read


Pharmacist-driven Treatment of Latent Tuberculosis Infection within a Gastroenterology Clinic: A Focus on Patients Requiring High Risk Medication Therapy or Those with Elevated Liver Enzymes
By Sarah Rinehart, PharmD, BCACP Patients with inflammatory bowel disease (IBD) are often treated with biologics or small molecules, including tumor necrosis factor (TNF)–α antagonists and corticosteroids.(1,2) Patients on these regimens with latent tuberculosis infection (LTBI) are at risk for reactivation of Mycobacterium tuberculosis to active tuberculosis (TB) disease.(3) Screening for LTBI using either TB blood tests (Interferon Gamma Release Assays [IGRAs] including
Oct 17, 20245 min read


Exploring Practice Barriers for Psychiatric Pharmacists to Address a Specialty Need
By Alexis Richardson, PharmD Candidate and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES It is estimated that 20% of adults in the United States experience mental health conditions every year, and 46% of adults aged 18 or older with any mental illness (AMI), received inpatient or outpatient mental health services or took prescription medication to treat a mental health condition in the last year.(1) These conditions include anxiety disorders, depression disorders, attention d
Aug 19, 20245 min read
bottom of page